Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (56)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kirchengast, S.
Right arrow Articles by Huber, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirchengast, S.
Right arrow Articles by Huber, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 16, No. 6, 1255-1260, June 2001
© 2001 European Society of Human Reproduction and Embryology

Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome

S. Kirchengast1,3 and J. Huber2

1 Institute for Anthropology, University of Vienna, A-1090 Vienna and 2 University Clinic for Gynecology and Obstetrics, Department for Endocrinology, A-1090 Vienna, Austria

Body composition, fat distribution and bone mineral density were examined in lean women suffering from polycystic ovary syndrome (PCOS) and compared with body composition and fat distribution characteristics of weight-matched lean controls. Ten women with PCOS and a body mass index (BMI) below 25.00 (kg/m2) and 10 healthy women with a BMI below 25.00 (kg/m2) matched for age and weight and BMI as controls were enrolled in this study. Body composition and bone density were measured by dual-energy- x-ray-absorptiometry and fat distribution patterns were calculated. Although matched for age, weight and BMI, lean PCOS patients showed a significantly higher amount of body fat and lower amount of lean body mass than the controls. The majority of PCOS patients showed an intermediate or android kind of fat distribution. Only 30% of the lean PCOS patients corresponded to the definition of gynoid fat distribution while this was true of all lean controls.

Key words: body composition/fat distribution/matched controls/PCOS

3 To whom correspondence should be addressed. E-mail: sylvia.kirchengast{at}univie.ac.at


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
D. Glintborg, M. Andersen, C. Hagen, L. Heickendorff, and A. P. Hermann
Association of Pioglitazone Treatment with Decreased Bone Mineral Density in Obese Premenopausal Patients with Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Trial
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1696 - 1701.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. M. Barber, S. J. Golding, C. Alvey, J. A. H. Wass, F. Karpe, S. Franks, and M. I. McCarthy
Global Adiposity Rather Than Abnormal Regional Fat Distribution Characterizes Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 999 - 1004.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
L. Ibanez, A. Jaramillo, G. Enriquez, E. Miro, A. Lopez-Bermejo, D. Dunger, and F. de Zegher
Polycystic ovaries after precocious pubarche: relation to prenatal growth
Hum. Reprod., February 1, 2007; 22(2): 395 - 400.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
D. Glintborg, M. Andersen, C. Hagen, J. Frystyk, V. Hulstrom, A. Flyvbjerg, and A. P. Hermann
Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls.
Eur. J. Endocrinol., August 1, 2006; 155(2): 337 - 345.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
L. Ibanez and F. de Zegher
Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women
Hum. Reprod. Update, May 1, 2006; 12(3): 243 - 252.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. I. Leibel, E. E. Baumann, M. Kocherginsky, and R. L. Rosenfield
Relationship of Adolescent Polycystic Ovary Syndrome to Parental Metabolic Syndrome
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1275 - 1283.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
L. Ibanez, C. Valls, and F. de Zegher
Discontinuous low-dose flutamide-metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism: normalizing effects on CRP, TNF-{alpha} and the neutrophil/lymphocyte ratio
Hum. Reprod., February 1, 2006; 21(2): 451 - 456.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Gonzalez, J. Minium, N. S. Rote, and J. P. Kirwan
Hyperglycemia Alters Tumor Necrosis Factor-{alpha} Release from Mononuclear Cells in Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5336 - 5342.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
M.A. Checa, A. Requena, C. Salvador, R. Tur, J. Callejo, J.J. Espinos, F. Fabregues, J. Herrero, and (Reproductive Endocrinology Interest Group of the
Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome
Hum. Reprod. Update, July 1, 2005; 11(4): 375 - 390.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Ibanez and F. d. Zegher
Flutamide-Metformin plus Ethinylestradiol-Drospirenone for Lipolysis and Antiatherogenesis in Young Women with Ovarian Hyperandrogenism: The Key Role of Metformin at the Start and after More than One Year of Therapy
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 39 - 43.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J. Schmid, S. Kirchengast, E. Vytiska-Binstorfer, and J. Huber
Infertility caused by PCOS--health-related quality of life among Austrian and Moslem immigrant women in Austria
Hum. Reprod., October 1, 2004; 19(10): 2251 - 2257.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Ibanez, C. Valls, M. V. Marcos, K. Ong, D. B. Dunger, and F. de Zegher
Insulin Sensitization for Girls with Precocious Pubarche and with Risk for Polycystic Ovary Syndrome: Effects of Prepubertal Initiation and Postpubertal Discontinuation of Metformin Treatment
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4331 - 4337.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Ibanez, C. Valls, S. Cabre, and F. de Zegher
Flutamide-Metformin Plus Ethinylestradiol-Drospirenone for Lipolysis and Antiatherogenesis in Young Women with Ovarian Hyperandrogenism: The Key Role of Early, Low-Dose Flutamide
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4716 - 4720.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
R. J. Norman, M. Noakes, R. Wu, M. J. Davies, L. Moran, and J. X. Wang
Improving reproductive performance in overweight/obese women with effective weight management
Hum. Reprod. Update, May 1, 2004; 10(3): 267 - 280.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Ibanez and F. de Zegher
Ethinylestradiol-Drospirenone, Flutamide-Metformin, or Both for Adolescents and Women with Hyperinsulinemic Hyperandrogenism: Opposite Effects on Adipocytokines and Body Adiposity
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1592 - 1597.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
V. BRUNI, M. DEI, V. PONTELLO, and P. VANGELISTI
The Management of Polycystic Ovary Syndrome
Ann. N.Y. Acad. Sci., November 1, 2003; 997(1): 307 - 321.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Ibanez and F. de Zegher
Flutamide-Metformin Therapy to Reduce Fat Mass in Hyperinsulinemic Ovarian Hyperandrogenism: Effects in Adolescents and in Women on Third-Generation Oral Contraception
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4720 - 4724.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Ibanez, K. Ong, A. Ferrer, R. Amin, D. Dunger, and F. de Zegher
Low-Dose Flutamide-Metformin Therapy Reverses Insulin Resistance and Reduces Fat Mass in Nonobese Adolescents with Ovarian Hyperandrogenism
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2600 - 2606.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
E. Tafeit, R. Moller, S. Rackl, A. Giuliani, W. Urdl, U. Freytag, K. Crailsheim, K. Sudi, and R. Horejsi
Subcutaneous Adipose Tissue Pattern in Lean and Obese Women with Polycystic Ovary Syndrome
Experimental Biology and Medicine, June 1, 2003; 228(6): 710 - 716.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. Schachter, A. Raziel, S. Friedler, D. Strassburger, O. Bern, and R. Ron-El
Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine
Hum. Reprod., April 1, 2003; 18(4): 721 - 727.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J.G. Dolfing, K.E. Tucker, C.M. Lem, J. Uittenbogaart, J.C. Verzijl, and D.H. Schweitzer
Low 11-deoxycortisol to cortisol conversion reflects extra-adrenal factors in the majority of women with normo-gonadotrophic normo-estrogenic infertility
Hum. Reprod., February 1, 2003; 18(2): 333 - 337.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Ibanez, N. Potau, A. Ferrer, F. Rodriguez-Hierro, M. V. Marcos, and F. de Zegher
Anovulation in Eumenorrheic, Nonobese Adolescent Girls Born Small for Gestational Age: Insulin Sensitization Induces Ovulation, Increases Lean Body Mass, and Reduces Abdominal Fat Excess, Dyslipidemia, and Subclinical Hyperandrogenism
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5702 - 5705.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.